emphysema treatment options

Emphysema Treatment Options

If you have been diagnosed with emphysema, your treatment options will probably be some of the first things you’ll discuss with your doctor. Emphysema, which is one of the prominent types of chronic obstructive pulmonary disease (COPD), will progressively make it harder to breathe. As such, the sooner you develop a treatment plan, the more effective you may be at minimizing symptoms.

The most common traditional treatment methods for emphysema include:

  • Medicated inhalers — Bronchodilators may be prescribed to relax the bronchiolar muscles and promote airflow in the lungs. Corticosteroids can also be prescribed to reduce inflammation.
  • Medication — Antibiotics are often prescribed to prevent or treat an antibacterial infection that can contribute to the symptoms of emphysema.
  • Oxygen therapy — Oxygen is typically used for those with more severe cases of emphysema. Oxygen can be used on either a full-time or supplemental basis, such as when the patient is at home or exercising, to increase blood oxygen levels.

The Lung Institute offers a viable alternative to treating emphysema: cellular therapy. Unlike traditional medications and therapy, which generally only address the condition’s symptoms and not its underlying causes, cellular therapy has been shown to potentially slow the progression of the disease and reduce lung inflammation. More than 80 percent of patients who have undergone treatment at the Lung Institute have reported an improvement in overall quality of life following one of our natural emphysema treatment options.

If you are interested in learning more about the natural emphysema treatment options we offer through our use of cellular therapy, call the dedicated Lung Institute team today at (800) 729-3065.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.